Therapeutic isoxazole compounds
US9650349B2 · kind B2 · utility
2Cited by
19References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 2015 |
| Grant date | May 16, 2017 |
| Priority date | — |
| Expiry date | May 11, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a compound of formula I:wherein A1, A2, A3, R1, X, Y, and B have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of monoamine oxidase B (MAO-B) enzyme function and are useful for improving cognitive function and for treating psychiatric disorders in animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.